AQEMIA
Entity
Description
  • Value proposition

    Scale Drug Discovery with Quantum-inspired Physics and AI

    AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

    Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
    Our most advanced programs are currently in vivo optimization.

    We are growing and hiring! Check our career website: https://jobs.lever.co/aqemia.com

    Discover the roles and behind-the-scenes at AQEMIA on our Welcome To The Jungle page: https://www.welcometothejungle.com/fr/companies/aqemia


    Pharmaceutical R&D, Artificial intelligence, drug hunting, drug design, Physics Based Technology, Quantum Physics, Machine Learning, Pharmaceuticals, PharmaTech, TechBio, Tech Platform, Computational Chemistry, Atomic Scale, Oncology, Cancer, Immuno-Oncology, AI Drug Discovery, Generative AI, and Drug Discovery

  • Original language

    Scale Drug Discovery with Quantum-inspired Physics and AI

    AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

    Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
    Our most advanced programs are currently in vivo optimization.

    We are growing and hiring! Check our career website: https://jobs.lever.co/aqemia.com

    Discover the roles and behind-the-scenes at AQEMIA on our Welcome To The Jungle page: https://www.welcometothejungle.com/fr/companies/aqemia

  • Aqemia - Discovering Drugs with Deep Physics and AI

    Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.

    • https://www.aqemia.com/
Corporate interactions BETA
Corporate TypeTweets Articles
CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services 		Other

17 Jun 2023


Consultor.fr
Consultor.fr
Media, Online Audio and Video Media
Consultor.fr
Media, Online Audio and Video Media 		Other

29 Oct 2022


Eurazeo Investment Manager
Eurazeo Investment Manager
Startup accelerator & VC, Venture Capital and Private Equity Principals
Eurazeo Investment Manager
Startup accelerator & VC, Venture Capital and Private Equity Principals 		Other

19 Oct 2022


Agoranov
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Agoranov
Startup accelerator & VC, Technology, Information and Internet 		Other

30 Apr 2024


Eurazeo
Eurazeo
Finance, Financial Services
Eurazeo
Finance, Financial Services 		Other

26 May 2024


Elaia
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals 		Not capitalistic
Partnership
Event

23 Jun 2022

30 Sep 2024



Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing 		Capitalistic
Partnership
Not event

8 Nov 2022


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Not capitalistic
Not partnership
Event

16 Nov 2021

8 Nov 2024



CNRS Innovation
CNRS Innovation
Research, Research Services
CNRS Innovation
Research, Research Services 		Not capitalistic
Partnership
Event

12 Feb 2024


Similar entities
Last news
Show all articles
Social network dynamics